  Mathematical modelling has successfully been used to provide quantitative
descriptions of many viral infections, but for the Ebola virus, which requires
biosafety level 4 facilities for experimentation, modelling can play a crucial
role. Ebola modelling efforts have primarily focused on in vivo virus kinetics,
e.g., in animal models, to aid the development of antivirals and vaccines. But,
thus far, these studies have not yielded a detailed specification of the
infection cycle, which could provide a foundational description of the virus
kinetics and thus a deeper understanding of their clinical manifestation. Here,
we obtain a diverse experimental data set of the Ebola infection in vitro, and
then make use of Bayesian inference methods to fully identify parameters in a
mathematical model of the infection. Our results provide insights into the
distribution of time an infected cell spends in the eclipse phase (the period
between infection and the start of virus production), as well as the rate at
which infectious virions lose infectivity. We suggest how these results can be
used in future models to describe co-infection with defective interfering
particles, which are an emerging alternative therapeutic.
